RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus (Q45372948)

13 December 2017

title

RNA interference therapy in lung transplant patients infected with respiratory syncytial virus (English)

1 reference

13 December 2017

RNA Interference Therapy in Lung Transplant Patients Infected with Respiratory Syncytial Virus (English)

1 reference

10.1164/RCCM.201003-0422OC

DOI

https://api.crossref.org/works/10.1164/RCCM.201003-0422OC

16 July 2024

1 reference

1 reference

Jens Gottlieb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851929

16 July 2024

Marie Budev

1 reference

13 December 2017

Mark Rolfe

1 reference

13 December 2017

Atul Humar

1 reference

13 December 2017

John Devincenzo

1 reference

13 December 2017

Akshay Vaishnaw

1 reference

13 December 2017

Jeffrey Cehelsky

1 reference

13 December 2017

Gary Albert

1 reference

13 December 2017

Sara Nochur

1 reference

13 December 2017

Martin R. Zamora

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851929

16 July 2024

Jared A. Gollob

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851929

16 July 2024

Allan R. Glanville

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851929

16 July 2024

language of work or name

English

0 references

publication date

17 September 2010

1 reference

full work available at URL

13 December 2017

http://ajrccm.atsjournals.org/cgi/content/abstract/183/4/531

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20851929

https://www.atsjournals.org/doi/pdf/10.1164/rccm.201003-0422OC

16 July 2024

1 reference

10.1164/RCCM.201003-0422OC

DOI

https://api.crossref.org/works/10.1164/RCCM.201003-0422OC

American Journal of Respiratory and Critical Care Medicine

16 July 2024

published in

1 reference

13 December 2017

volume

183

1 reference

13 December 2017

1 reference

13 December 2017

page(s)

531-538

1 reference

Community respiratory viruses: organ transplant recipients

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Community respiratory virus infections following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

A single-season prospective study of respiratory viral infections in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

RNA interference. The short answer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Interfering with disease: a progress report on siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Protection against lethal influenza virus challenge by RNA interference in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Inhibition of respiratory viruses by nasally administered siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Estimates of Location Based on Rank Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Activation of the mammalian immune system by siRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201003-0422OC

10.1164/RCCM.201003-0422OC

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference